Table 3.
EBV LMP-1 patterns in 23 subjects with whole genome sequence extracted from BLGSP, including 14 with samples in EMBLEM who were also genotyped in this study using the Sanger method.
Case ID | WGS depth | EBV type | LMP-1 Pattern from WGS | LMP-1 pattern from Sanger | ||
---|---|---|---|---|---|---|
Tumor | Normal | Tumor | Normal | Normal | ||
Nine Paired BLGSP samples of tumor and buccal (normal) samples* | ||||||
BLGSP-71-06-00012 | 1525.09 | 10.20 | 1 | F | F | – |
BLGSP-71-06-00020 | 549.83 | 569.85 | 1 | D | D | – |
BLGSP-71-06-00072 | 773.10 | 724.81 | 2 | AI | AI | – |
BLGSP-71-06-00076 | 1129.61 | 144.91 | 1 | AIII | AIII | – |
BLGSP-71-06-00143 | 1275.68 | 240.18 | 1 | D | D | – |
BLGSP-71-06-00146 | 655.55 | 27.22 | 1 | ABIII | ABIII | – |
BLGSP-71-06-00251 | 1708.80 | 3848.28 | 1/2 | AIII | AVI | – |
BLGSP-71-06-00255 | 2972.55 | 358.95 | 1 | AIII | AIII | – |
BLGSP-71-06-00277 | 3965.62 | 15.03 | 1 | F | n/a | – |
14 paired BLGSP samples of tumor and blood (normal) samples and Sanger data from LMP-1 gene targeted PCR sequencing in the EMBLEM study | ||||||
BLGSP-71-08-00033 | 1492.4 | 1.1 | 2 | D | n/a | D |
BLGSP-71-08-00036 | 645.5 | 1.0 | 2 | D | n/a | D |
BLGSP-71-08-00038 | 1055.9 | 1.6 | 1 | D | n/a | AB7 |
BLGSP-71-08-00041 | 1766.1 | 1.3 | 1 | D | n/a | A3 |
BLGSP-71-08-00050# | 1424.7 | 4.3 | n/a | ABII | n/a | ABII |
BLGSP-71-08-00191# | 3.6 | 1.8 | n/a | NA | n/a | n/a |
BLGSP-71-08-00194 | 2705.2 | 15.2 | 1 | AIII | AIII | n/a |
BLGSP-71-08-00197 | 3053.0 | 32.6 | 1 | I | I | K |
BLGSP-71-08-00199 | 2914.7 | 3.6 | 1 | I | n/a | n/a |
BLGSP-71-08-00200 | 1526.9 | 2.9 | 1 | D | n/a | D |
BLGSP-71-08-00204 | 2818.9 | 2.5 | 1 | ABII | n/a | AB7 |
BLGSP-71-08-00205 | 1116.6 | 3.4 | 1 | D | n/a | n/a |
BLGSP-71-08-00206 | 3558.9 | 2.9 | 1 | I | n/a | I |
BLGSP-71-08-00210 | 1776.2 | 3.1 | 1 | D | n/a | K |